These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16003343)

  • 1. Teva to acquire Chinese biogenerics manufacturer.
    Katsnelson A
    Nat Biotechnol; 2005 Jul; 23(7):765. PubMed ID: 16003343
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural resources: bioprospects less than golden.
    Dalton R
    Nature; 2004 Jun; 429(6992):598-600. PubMed ID: 15190324
    [No Abstract]   [Full Text] [Related]  

  • 3. Investor volatility plagues drug companies on new Chinese exchange.
    Mitchell P; Jing F
    Nat Biotechnol; 2010 Jan; 28(1):9-10. PubMed ID: 20062025
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 5. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 6. The policy outlook from the Hill.
    Vastag B
    Nat Biotechnol; 2007 Jan; 25(1):13-6. PubMed ID: 17211381
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech battle royale. Two firms fight over billion-dollar drug.
    Sherrid P
    US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209
    [No Abstract]   [Full Text] [Related]  

  • 8. Bills target biosimilar drugs.
    Wadman M
    Nature; 2009 Mar; 458(7237):394-5. PubMed ID: 19325595
    [No Abstract]   [Full Text] [Related]  

  • 9. Sarbanes-Oxley rules to be relaxed?
    Lawrence S
    Nat Biotechnol; 2006 Jul; 24(7):731-2. PubMed ID: 16841042
    [No Abstract]   [Full Text] [Related]  

  • 10. Industrial health research in Canada.
    Morin Y
    CMAJ; 2007 Jun; 176(12):1734; author reply 1734. PubMed ID: 17548390
    [No Abstract]   [Full Text] [Related]  

  • 11. The perils of federalizing vaccine production.
    Kazman S; Miller HI
    Nat Biotechnol; 2002 Feb; 20(2):113. PubMed ID: 11821845
    [No Abstract]   [Full Text] [Related]  

  • 12. Bad medicine.
    Sheridan C
    Nat Biotechnol; 2007 Jul; 25(7):707-9. PubMed ID: 17621284
    [No Abstract]   [Full Text] [Related]  

  • 13. Bring the magic back to the bullets.
    Nat Biotechnol; 2006 Dec; 24(12):1489. PubMed ID: 17160046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 15. Patently absurd?
    Garber K
    Nat Biotechnol; 2006 Jul; 24(7):737-9. PubMed ID: 16841046
    [No Abstract]   [Full Text] [Related]  

  • 16. Meeting in the middle.
    Nature; 2007 Jun; 447(7145):629. PubMed ID: 17554281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 18. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 19. Ignore the Delaware director-compensation cases at your peril.
    Lilienfeld D; Polovoy B; Kessel M
    Nat Biotechnol; 2016 Apr; 34(4):373-4. PubMed ID: 27054986
    [No Abstract]   [Full Text] [Related]  

  • 20. Barnyard biotech--lame duck or golden goose?
    Powell K
    Nat Biotechnol; 2003 Sep; 21(9):965-7. PubMed ID: 12949546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.